Molecular Mechanisms of APOL1-Associated Kidney Disease
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27062863 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Charlotte Delrue und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium. Hauptthemen laut MEDLINE: Apolipoprotein L1, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The discovery of apolipoprotein L1 (APOL1) risk polymorphisms has significantly changed our knowledge of kidney disease susceptibility and development in African American populations. Several non-diabetic kidney disorders, such as focal segmental glomerulosclerosis (FSGS), collapsing glomerulopathy, HIV-associated nephropathy (HIVAN), and accelerated chronic kidney disease (CKD) development, are significantly more likely to occur in people with two coding variations, G1 and G2. The significance of context-dependent pathogenic processes is highlighted by the poor penetrance and remarkable phenotypic variety of APOL1-associated kidney disease, despite its substantial impact. This review synthesizes current knowledge of APOL1 biology through a molecular framework, emphasizing gain-of-toxic-function effects of risk variants in podocytes, dysregulated ion fluxes, mitochondrial dysfunction, impaired proteostasis, and activation of innate immune and inflammatory signaling pathways. We describe how the well-recognized “second-hit” paradigm has a biological basis, driven by strong inducibility by interferons and immunological activation, as well as strict basal regulation of APOL1 expression. Lastly, we explore future approaches to precision nephrology and highlight translational advancements, such as APOL1 gene-silencing techniques. This review provides a mechanistic roadmap for translating APOL1 biology into targeted therapeutic strategies by integrating genetics, cell biology, immunology, and systems-level approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
- Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
- Research Foundation-Flanders (FWO), 1000 Brussels, Belgium.
ORCID-Profile: Reinhart Speeckaert, Marijn M Speeckaert
Zitieren
APA
Delrue, C., Speeckaert, R., & Speeckaert, M. M. (2026). Molecular Mechanisms of APOL1-Associated Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062863
Vancouver
Delrue C, Speeckaert R, Speeckaert MM. Molecular Mechanisms of APOL1-Associated Kidney Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062863
BibTeX
@article{Delrue2026,
author = {Delrue, Charlotte and Speeckaert, Reinhart and Speeckaert, Marijn M},
title = {Molecular Mechanisms of APOL1-Associated Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27062863}
}
EUVIMED